Two doses of the Pfizer or Moderna COVID-19 vaccine were less effective at preventing hospitalizations during the omicron BA.2 and BA.2.12.1 periods than during the BA.1 period, but a third and fourth dose provided additional protection to eligible adults, the Centers for Disease Control and Prevention reported Friday. Based on data from 10 states, two doses were 61% effective against hospitalization during the BA.1 period and 24% effective during the BA.2/BA.2.12.1 period, increasing to 85%-92% and 52%-69% effective, respectively, after a third dose. Among adults aged 50 and older, vaccine effectiveness against hospitalization during BA.2/BA.2.12.1 increased to 80% after a fourth dose, the study found.

“Getting vaccinated now will not prevent you from getting an authorized variant-specific vaccine in the fall or winter when they are recommended for you,” CDC said. “Given recent increases in deaths and hospitalizations associated with the BA.5 variant, everyone should stay up to date with recommended COVID-19 vaccinations, including additional booster doses for those who are moderately to severely immunocompromised and adults over 50.”
 

Headline
The Wisconsin Department of Health Services announced Nov. 13 that a second child in the state died of measles amid its ongoing outbreak. As of Nov. 13, the…
Headline
Pennsylvania has recorded its seventh measles-associated death this year as a statewide outbreak of the virus continues, according to an update Nov. 13 by the…
Headline
The Wisconsin Department of Health Services reported Nov. 5 that an infant died of measles, marking the first measles-associated death in the state since 1990.…
Headline
The New York State Department of Health announced Nov. 2 that a child died of measles amid the state’s ongoing outbreak and is the first known measles…
Headline
There have been 1,398 confirmed cases of measles in Pennsylvania this year, according to data released Oct. 28 by the Pennsylvania Department of Health. Data…
Headline
The Centers for Disease Control and Prevention reported 798 laboratory-confirmed flu-associated hospitalizations for the week ending Oct. 17. The weekly…